Page last updated: 2024-10-31

mirtazapine and B-Cell Chronic Lymphocytic Leukemia

mirtazapine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Pauli, F1
Berger, T1
Walder, A1
Maier, H1
Rhomberg, P1
Uprimny, C1
Steurer, M1
Stockhammer, G1
Lutz, M1
Schulze, AB1
Rebber, E1
Wiebe, S1
Zoubi, T1
Grauer, OM1
Keßler, T1
Kerkhoff, A1
Lenz, G1
Berdel, WE1

Other Studies

2 other studies available for mirtazapine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 60, Issue:4

    Topics: Cytarabine; Disease Progression; Female; Humans; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; L

2014
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
    Cancer research and treatment, 2017, Volume: 49, Issue:2

    Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease

2017